Status:

COMPLETED

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance

Lead Sponsor:

Radboud University Medical Center

Conditions:

HIV-infection

Pregnancy

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

The primary objective of this two-phase trial is as follows: * To determine the elimination half-life of NVP in HIV positive pregnant women receiving it as a single dose in labour in addition to the ...

Detailed Description

This trial (VITA2) will be done with phenytoin as enzyme inducer to decrease the elimination half-life of NVP as it has also shown a significant difference in the elimination half-life of NVP in the E...

Eligibility Criteria

Inclusion

  • HIV-infected as documented by positive HIV antibody test
  • Antiretroviral naïve
  • Starting ARV prophylaxis from 28th weeks of gestation or at least 4 weeks before delivery
  • Not intending to relocate out of the area for the duration of study participation
  • Willingness of subject to adhere to follow up schedule (note: this is more intensive for the pilot PK phase)
  • Ability and willingness of subject to give written consent
  • Pregnant women aged 18 years and above
  • Willing and able to regularly attend the antenatal clinic

Exclusion

  • Serious illness that requires systemic treatment or hospitalization
  • Use of concomitant medication, which interferes with the ARV prophylaxis for PMTCT or phenytoin
  • Any condition that in the opinion of the investigator would compromise the subjects' ability to participate in the study
  • Previously treated for HIV infection with antiretroviral agents, including ARV prophylaxis for PMTCT
  • Inability to understand the nature and extent of the trial and the procedures required
  • CD4 count \<350 cells/µl because such a patient is eligible for HAART

Key Trial Info

Start Date :

May 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2012

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT01187719

Start Date

May 1 2010

End Date

September 1 2012

Last Update

December 1 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kilimanjaro Christian Medical Centre

Moshi, Kilimanjaro, Tanzania

2

University Teaching Hospital

Lusaka, Zambia

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance | DecenTrialz